The ERS Research Agency: the beginning

被引:11
作者
Soriano, Joan B. [1 ]
Paton, James [2 ]
Burrieza, Fernando Martin [3 ]
Bill, Werner [3 ]
Pannetier, Carine [4 ]
Aliberti, Stefano [5 ]
Adcock, Ian M. [6 ]
Wagers, Scott [7 ]
Migliori, Giovanni Battista [8 ]
机构
[1] Univ Autonoma Madrid, Catedra UAM Linde, Inst Invest Hosp Univ Princesa IISP, Madrid, Spain
[2] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland
[3] European Resp Soc, ERS Execut Off, Lausanne, Switzerland
[4] European Resp Soc, ERS Sci & Educ, Lausanne, Switzerland
[5] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy
[6] Imperial Coll London, Fac Med, Natl Heart & Lung Inst, Cell & Mol Biol,Airways Dis Sect, London, England
[7] BioSci Consulting, Maasmechelen, Belgium
[8] Fdn S Maugeri, Care & Res Inst, WHO Collaborating Ctr TB & Lung Dis, I-21049 Tradate, Italy
关键词
D O I
10.1183/13993003.02109-2015
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
100201 [内科学];
摘要
There is at the current time a significant opportunity for the ERS to leverage its experience and reputation as an international umbrella organisation to promote high-quality, multinational respiratory research with the goal of improving the health of respiratory patients. This editorial proposes a model for the role and structure of an ERS Research Agency. It is based upon research, implicit knowledge and explicit feedback from ERS members and selected external individuals and organisations. As with any new endeavour there are challenges and threats. Building a Research Agency will be a major undertaking that will require significant organisational planning, resources, effort and commitment. Organisations with multiple stakeholders tend to have a status quo inertia that has to be overcome for any significant new endeavour. The ERS Research Agency could be an investment in the future of respiratory research.
引用
收藏
页码:1017 / 1023
页数:7
相关论文
共 12 条
[2]
Sharing Individual Patient Data from Clinical Trials [J].
Drazen, Jeffrey M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (03) :201-202
[3]
Reform of Clinical Research Regulations, Finally [J].
Emanuel, Ezekiel J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (24) :2296-2299
[4]
Gibson J, 2013, EUROPEAN LUNG WHITE BOOK: RESPIRATORY HEALTH AND DISEASE IN EUROPE, P1
[5]
Grether Megan, 2014, Lancet Respir Med, V2, pe13, DOI 10.1016/S2213-2600(14)70150-X
[6]
The relation between funding by the National Institutes of Health and the burden of disease [J].
Gross, CP ;
Anderson, GF ;
Rowe, NR .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (24) :1881-1887
[7]
Drug development for airway diseases: looking forward [J].
Holgate, Stephen ;
Agusti, Alvar ;
Strieter, Robert M. ;
Anderson, Gary P. ;
Fogel, Robert ;
Bel, Elisabeth ;
Martin, Thomas R. ;
Reiss, Theodore F. .
NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (06) :367-368
[8]
The European Respiratory Society plans its future: the 2013-2018 strategic plan [J].
Migliori, Giovanni Battista ;
Rabe, Klaus F. ;
Bel, Elisabeth ;
Elliott, Mark ;
Gaga, Mina ;
Holgate, Stephen T. ;
Joos, Guy ;
Burrieza, Fernando Martin ;
Sax, Betty ;
Sculier, Jean-Paul ;
Simonds, Anita K. ;
Blasi, Francesco ;
Barnes, Peter J. .
EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (04) :927-932
[9]
Ries E, 2011, LEAN STARTUP TODAYS, P103
[10]
The current state of respiratory research in the UK [J].
Snell, Noel ;
Jarrold, Ian ;
Holgate, Stephen .
THORAX, 2015, 70 (11) :1011-1013